JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beyer, K. H.
Right arrow Articles by Kemp, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beyer, K. H.
Right arrow Articles by Kemp, R. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 103, Issue 1, 79-92, 1951
Copyright © 1951 by American Society for Pharmacology and Experimental Therapeutics


3-HYDROXY-2-PHENYLCINCHONINIC ACID (HPC): ITS ABSORPTIOX, EXCRETION, AND ITS EFFECTS ON CERTAIN RENAL FUNCTIONS AND ENZYME SYSTEMS

Karl H. Beyer 1, Horace F. Russo 1, Grace S. Schuchardt 1, Jacqueline A. Fishman 1, Virgil D. Wiebelhaus 1, and Robert L. Kemp 1

1 The Pharmacology Section, Research Division, Sharp and Dohme, Inc., Glenolden, Pa.

Certain cinchoninic acid derivatives, particularly 3-hydroxy-2-phenylcinchoninic acid (HPC), are unusual with regard to the multiplicity of pharmacodynamic actions that are resident in a single type of structure. The antidiuretic effect that is manifested acutely hut not during chronic administration, the depression of the cardiovascular system when HPC is administered rapidly by venoclysis, the inhibition of intestinal activity and the several other effects to which reference has been made serve as examples of these broad actions of HPC.

HPC appears to be well absorbed from the gastrointestinal tract although itspeak blood level frequently occurs several hours following its oral administration. Its renal clearance is unusually low and the duration of its determinable blood level following a given dose persists for many hours. Although the greater than 90 per cent binding to plasma protein contributes to its renal economy, it is probable that reabsorption of most of the glomerular ultrafiltered increment and a Slow rate of metabolism also account in large measure for its persistence in the body.

The inhibition of phenol red, PAH and penicillin renal tubular secretions by HPC and its enzymologic characteristics as they relate to the inhibition of PAB conjugation without affecting glucose transphosphorylation suggest that this effect of HPC is analogous to those of carinamide and Benemid. However, except for this point of similarity the two types of compounds differ almost qualitatively in the specificity of action of the former group and the multiplicity of the pharmacodynamic actions of HPC. This suggests that additional fundamental studies of the enzymologic properties of this agent should prove fruitful.

Submitted on June 20, 1951







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1951 by the American Society for Pharmacology and Experimental Therapeutics.